peptide receptor - Robuta Search

https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.896287/full Frontiers | Peptide Receptor Radionuclide Therapy in Thyroid Cancer The treatment options that are currently available for the management of metastatic, progressive radioiodine (RAI)-refractory differentiated thyroid cancers ... peptide receptor radionuclide therapy frontiers thyroid cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC10251822/ Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements - PMC This article discusses the use of peptide receptor radionuclide therapy (PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It... peptide receptor radionuclide therapy prrt innovations improvements https://www.ebi.ac.uk/chembl/explore/target/CHEMBL4227 Target: N-formyl peptide receptor 2 (CHEMBL4227) - ChEMBL Report card for Target N-formyl peptide receptor 2 (CHEMBL4227). Homo sapiens, SINGLE PROTEIN, FMLP-related receptor I, FMLP-R-I, Formyl peptide receptor-like... formyl peptide receptor 2 target n chembl https://www.thermofisher.com/antibody/primary/panther/natriuretic%20peptide%20receptor%20activity natriuretic peptide receptor activity Antibodies | Invitrogen Antibodies for proteins involved in natriuretic peptide receptor activity pathways, according to their Panther/Gene Ontology Classification natriuretic peptide receptor activity antibodies invitrogen https://www.spandidos-publications.com/10.3892/or.2025.8922 [Retracted] Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and... Oncology Reports is an international journal devoted to fundamental and applied research in Oncology. formyl peptide receptor 2 https://www.ncbi.nlm.nih.gov/gene/2358 FPR2 formyl peptide receptor 2 [Homo sapiens (human)] - Gene - NCBI formyl peptide receptor 2 homo sapiens human gene fpr2 ncbi https://www.biospace.com/molecular-targeting-technologies-inc-to-present-evathera-long-acting-peptide-receptor-radionuclide-therapy-platform-at-biofuture-2023 Molecular Targeting Technologies, Inc. to Present EvaThera, Long-Acting Peptide Receptor... Oct 5, 2023 - Molecular Targeting Technologies, Inc., is presenting at BioFuture 2023 on Thursday 2:45 PM, Oct 5th, at Lotte New York Palace hotel. molecular targeting technologies inc https://www.jci.org/articles/view/15595/table/1 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC10423473/ Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis... Obesity is a risk factor for knee osteoarthritis (KOA) development and progression. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicated for type... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC10801460/ The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping... Background: Obstructive sleep apnoea (OSA) and associated hypopnoea syndromes are chronic conditions of sleep-disordered breathing with significant sequelae if... glucagon like peptide 1 https://www.rcsb.org/structure/6VMC RCSB PDB - 6VMC: T4H2 T cell receptor bound to HLA-A2 presenting gp100T2L peptide (ILDQVPFSV) T4H2 T cell receptor bound to HLA-A2 presenting gp100T2L peptide (ILDQVPFSV) https://www.preprints.org/manuscript/202301.0053 Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor[v1] |... Advances in nanomedicine bring the attention of researchers to the molecular targets which can play a major role in the development of novel therapeutic and... gastrin releasing peptide https://pmc.ncbi.nlm.nih.gov/articles/PMC7047699/ Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for... Headaches and migraines continue to be a leading cause of suffering and disability. As per the Global Burden of Disease Survey conducted in 2010, the exact... a novel https://www.healthday.com/healthpro-news/mental-health/glucagon-like-peptide-1-receptor-agonists-may-be-treatment-for-alcohol-use-disorder Glucagon-Like Peptide-1 Receptor Agonists May Aid Alcohol Use Disorder Glucagon-like peptide-1 receptor agonists may be a potential novel treatment for alcohol use disorder. glucagon like peptide 1 receptor agonists alcohol use https://www.ncbi.nlm.nih.gov/Structure/pdb/6VMA 6VMA: T4H2 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV) Beta-2-microglobulinMHC class I antigen, A-2 alpha chainMelanocyte protein PMELT4H2 T cell receptor alpha chainT4H2 T cell receptor beta chain t cell receptor https://pmc.ncbi.nlm.nih.gov/articles/PMC19698/ The cleaved peptide of the thrombin receptor is a strong platelet agonist - PMC Thrombin cleaves its G-protein-linked seven-transmembrane domain receptor, thereby releasing a 41-aa peptide and generating a new amino terminus that acts as a... thrombin receptor https://pmc.ncbi.nlm.nih.gov/articles/PMC4216654/ Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists - PMC Patients with type 2 diabetes have a several-fold increased risk of developing cardiovascular disease when compared with nondiabetic controls. Myocardial... glucagon like peptide 1 receptor agonists cardiovascular effects https://www.ncbi.nlm.nih.gov/protein/3WSY_C Chain C, peptide from Sortilin-related receptor - Protein - NCBI c peptide receptor protein chain related ncbi https://www.rcsb.org/structure/1D01 RCSB PDB - 1D01: STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A HUMAN CD30 PEPTIDE https://www.rcsb.org/structure/3D32 RCSB PDB - 3D32: Complex of GABA(A) receptor-associated protein (GABARAP) with a synthetic peptide Complex of GABA(A) receptor-associated protein (GABARAP) with a synthetic peptide https://pmc.ncbi.nlm.nih.gov/articles/PMC12322966/ Severe reflux oesophagitis caused by repeated vomiting due to glucagon-like peptide-1 receptor... glucagon like peptide 1 https://www.rcsb.org/structure/5GTR RCSB PDB - 5GTR: estrogen receptor alpha in complex with a stabilized peptide antagonist 6 estrogen receptor alpha in complex with a stabilized peptide antagonist 6 https://www.jci.org/articles/view/15595/figure/7 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://www.wikidata.org/wiki/Q42612551 The peptide product of a 5' leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor... scientific article published on February 1994 https://www.jci.org/articles/view/194752 JCI - Signaling architecture of the glucagon-like peptide-1 receptor glucagon like peptide 1 of the jci signaling architecture https://pmc.ncbi.nlm.nih.gov/articles/PMC8961394/ Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been widely recommended for glucose control and cardiovascular risk reduction in patients with type... glucagon like peptide 1 https://www.wikidata.org/wiki/Q40996486 Peptide antagonism and T cell receptor interactions with peptide-MHC complexes - Wikidata scientific article published on October 1998 t cell receptor peptide antagonism https://pmc.ncbi.nlm.nih.gov/articles/PMC9992880/ Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on... The occurrence of obesity is an increasing issue worldwide, especially in industrialized countries. Weight loss is important both to treat obesity and to... https://pmc.ncbi.nlm.nih.gov/articles/PMC8796881/ Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among... Are there inequities in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use based on race, ethnicity, sex, and socioeconomic status among patients with... glucagon like peptide 1 https://www.jci.org/articles/view/15595/figure/5 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2017.00146/full Frontiers | The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks... 3,4-methylenedioxymethamphetamine (MDMA) and its derivatives, 2,5-dimethoxy-4-bromo-amphetamine hydrobromide (DOB) and para-methoxyamphetamine (PMA) are rec... non peptide arginine vasopressin https://www.jci.org/articles/view/85679/figure/7 JCI - Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide... t cell receptor https://elifesciences.org/articles/82813/figures Figures and data in Structure-based prediction of T cell receptor:peptide-MHC interactions | eLife The AlphaFold protein structure prediction network can be specialized for T cell receptor docking, leading to improved models of ternary complexes and some... https://pmc.ncbi.nlm.nih.gov/articles/PMC7911747/ Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and... To assess the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for treatment of nonalcoholic fatty liver disease (NAFLD) or steatohepatitis... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC18790/ Combinatorial peptide libraries reveal the ligand-binding mechanism of the oligopeptide receptor... The oligopeptide transport system (Opp) of Lactococcus lactis has the unique capacity to mediate the transport of peptides from 4 up to at least 18 residues.... combinatorial peptide ligand binding libraries reveal https://pmc.ncbi.nlm.nih.gov/articles/PMC12411144/ Cost-Effectiveness of Obesity Treatments: Glucagon-Like Peptide-1 Receptor Agonists, Endoscopic... Obesity represents a major global health challenge, requiring interventions that are both effective and economically sustainable. This review examines the... glucagon like peptide 1 cost effectiveness https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.984198/full Frontiers | Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2... Owing to the increasing prevalence of type 2 diabetes, the development of novel hypoglycemic drugs has become a research hotspot, with the ultimate goal of d... https://www.jci.org/assets/328880/powerpoint JCI - A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I... https://pmc.ncbi.nlm.nih.gov/articles/PMC7434819/ A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2... Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a well-established class of glucose-lowering drugs. GLP-1 RAs can be classified according to their... https://www.ncbi.nlm.nih.gov/protein/6K3F_Z Chain Z, Peptide from Atypical chemokine receptor 3 - Protein - NCBI chemokine receptor 3 chain z peptide atypical https://pmc.ncbi.nlm.nih.gov/articles/PMC10563602/ Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned? - PMC Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from... https://pmc.ncbi.nlm.nih.gov/articles/PMC12421399/ Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future... Obesity is a global pandemic that has been threatening the worldwide population. It has been reported to be associated with an increase in the risk of chronic... glucagon like peptide 1 receptor agonists https://www.jci.org/articles/view/15595/figure/2 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://www.rug.nl/about-ug/latest-news/news/archief2014/promoties/promotie-g.-carlucci_-strategies-for-gastrin-releasing-peptide-receptor-targeted-imaging-in-pros Phd ceremony G. Carlucci: Strategies for gastrin releasing peptide receptor targeted imaging in... Mar 13, 2020 - Prostate cancer (PCa) is most commonly diagnosed in men over the age of 50, but the genetic history of their family is already an indication of a... gastrin releasing peptide https://www.jci.org/articles/view/15595/figure/6 JCI - Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC12048073/ A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus... Glucagon-like peptide-1 receptor agonists (GLP1-RA) are an emerging class of medications with demonstrated promise in improving cardiometabolic outcomes.... glucagon like peptide 1 https://pmc.ncbi.nlm.nih.gov/articles/PMC10998705/ Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review - PMC Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective medications for the treatment of type 2 diabetes and obesity. Pharmacological... glucagon like peptide 1 https://www.ncbi.nlm.nih.gov/Structure/pdb/7KNU 7KNU: CryoEM structure of the CGRP receptor with bound CGRP peptide in a detergent micelle Calcitonin gene-related peptide 1Calcitonin gene-related peptide type 1 receptorReceptor activity-modifying protein 1 https://www.jci.org/articles/view/89919 JCI - Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide... t cell receptor https://www.ncbi.nlm.nih.gov/protein/4ZNU_D Chain D, Nuclear receptor-interacting peptide - Protein - NCBI nuclear receptor chain interacting peptide protein https://pmc.ncbi.nlm.nih.gov/articles/PMC10775775/ Medicare formulary restrictions for glucagon-like peptide 1 receptor agonists and sodium glucose... Glucagon-like peptide 1 receptor agonists (GLP1-RAs) and sodium glucose cotransporter 2 inhibitors (SGLT2is) have proven benefits in patients with type 2... glucagon like peptide 1 https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-03863&r=1 A Vaccine (MUC1 Peptide-Poly-ICLC) for the Treatment of Estrogen Receptor Positive Breast Ductal... A Vaccine (MUC1 Peptide-Poly-ICLC) for the Treatment of Estrogen Receptor Positive Breast Ductal Carcinoma in Situ https://www.ncbi.nlm.nih.gov/protein/6K3F_X Chain X, Peptide from Atypical chemokine receptor 3 - Protein - NCBI chemokine receptor 3 chain x peptide atypical https://pmc.ncbi.nlm.nih.gov/articles/PMC12664052/ All-cause mortality and cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a popular first-line treatment option in managing Type 2 Diabetes Mellitus (T2DM) with cardiovascular... glucagon like peptide 1 all cause mortality https://elifesciences.org/articles/52212 MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism... Class 1 histone deacetylase (HDAC) inhibitor MS-275 enhances the efficacy of glucagon-like peptide 1 receptor (GLP-1R) therapy for glycemic control and... https://www.wikidata.org/wiki/Q41186190 A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor... scientific article published on July 1996 adrenergic receptor transmembrane domain peptide derived beta2 https://www.rcsb.org/structure/4OAJ RCSB PDB - 4OAJ: Crystal structure of the complex between SAP97 PDZ2 and 5HT2A receptor peptide Crystal structure of the complex between SAP97 PDZ2 and 5HT2A receptor peptide https://pmc.ncbi.nlm.nih.gov/articles/PMC9357557/ Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management:... Obesity and overweight pose a threat to health and are more common than undernutrition among adults. It is categorized by fat accumulation and a body mass... glucagon like peptide 1 https://www.ncbi.nlm.nih.gov/Structure/pdb/8D51 8D51: Parathyroid hormone 1 receptor extracellular domain complexed with a peptide ligand... PTHrP[1-36]Parathyroid hormone/parathyroid hormone-related peptide receptor1,2-ETHANEDIOLZINC ION parathyroid hormone extracellular domain https://pmc.ncbi.nlm.nih.gov/articles/PMC8086144/ A novel peptide antagonist of the human growth hormone receptor - PMC Excess circulating human growth hormone (hGH) in vivo is linked to metabolic and growth disorders such as cancer, diabetes, and acromegaly. Consequently, there... human growth hormone of the novel peptide antagonist https://www.ebi.ac.uk/chembl/explore/document/CHEMBL5335795 Document: Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and... Report card for Document Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models.... formyl peptide receptor 1 https://www.ncbi.nlm.nih.gov/protein/6LBG_B Chain B, Protein fem-1 homolog C,Peptide from Olfactory receptor 51B2 - Protein - NCBI https://www.rug.nl/about-ug/latest-news/news/archief2014/promoties/promotie-g.-carlucci_-strategies-for-gastrin-releasing-peptide-receptor-targeted-imaging-in-pros?lang=en Phd ceremony G. Carlucci: Strategies for gastrin releasing peptide receptor targeted imaging in... Mar 13, 2020 - Prostate cancer (PCa) is most commonly diagnosed in men over the age of 50, but the genetic history of their family is already an indication of a... gastrin releasing peptide https://www.rcsb.org/structure/1AO7 RCSB PDB - 1AO7: COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 https://www.osti.gov/pages/biblio/1460885-stress-testing-relationship-between-cell-receptor-peptide-mhc-affinity-cross-reactivity-using-peptide-velcro Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity... The U.S. Department of Energy's Office of Scientific and Technical Information https://elifesciences.org/articles/82813 Structure-based prediction of T cell receptor:peptide-MHC interactions | eLife The AlphaFold protein structure prediction network can be specialized for T cell receptor docking, leading to improved models of ternary complexes and some... t cell receptor structure based prediction https://pmc.ncbi.nlm.nih.gov/articles/PMC12293269/ Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder - PMC Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were originally developed for managing type 2 diabetes by enhancing insulin... glucagon like peptide 1